Bovine Mastitis Market Size & Growth Forecast 2026–2035, By Segments (Product, Type, Therapy, Route of Administration, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Bovine Mastitis Market size stood at USD 1.77 Billion in 2025 and is predicted to grow at a 8.3% CAGR from 2026 to 2035, attaining USD 3.93 Billion by 2035. The industry revenue for 2026 is assessed at USD 1.9 billion.
Get more details on this report
Request Free Sample ReportBovine Mastitis Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 40.00% share, supported by large commercial dairy herds, established veterinary networks, and routine on-farm diagnostics and treatment practices.
- Asia Pacific grows at 9.38% CAGR due to dairy modernization, rising productivity focus, and expanding adoption of structured herd health and mastitis control systems.
Segment Momentum
- Pharmaceuticals held a 61.95% share in 2025 because they remain the primary treatment for active mastitis infections, with antibiotics and supportive therapies routinely used in veterinary practice and farm treatment protocols.
- Vaccines are growing fastest as dairy producers increasingly adopt preventive herd health strategies to reduce recurring infections, strengthen udder health management, and lessen reliance on repeated pharmaceutical treatments.
Market Expansion Drivers
- Rising global dairy consumption increasing demand for effective udder infection management solutions.
- Advancements in molecular diagnostics improving early detection and treatment accuracy for mastitis.
- Growing awareness of subclinical mastitis driving preventive veterinary healthcare adoption.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Major players in the bovine mastitis market include Zoetis Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Elanco Animal Health Incorporated (United States), Merck & Co., Inc. (United States), Ceva Santé Animale S.A. (France), HIPRA, S.A. (Spain), Virbac S.A. (France), ImmuCell Corporation (United States), Forte Healthcare Limited (New Zealand), Dechra Pharmaceuticals PLC (United Kingdom).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As dairy intake rises, producers face stronger pressure to maintain consistent milk output, herd productivity, and raw milk quality, which directly increases spending on prevention and treatment tools in the bovine mastitis market. Mastitis reduces yield, alters milk composition, and can trigger milk discard during treatment periods, so higher-value dairy production systems tend to adopt faster intervention protocols, routine udder health monitoring, and more reliable therapeutic products to protect farm economics. This dynamic is encouraging market growth for antibiotics, teat sealants, disinfectants, and herd health management services as commercial dairies become less willing to absorb losses linked to avoidable udder infections.
Advancements in molecular diagnostics improving early detection and treatment accuracy for mastitis
Improved molecular testing is reshaping clinical decision-making in the bovine mastitis market by allowing veterinarians and dairy operators to identify causative pathogens earlier and with greater precision than conventional methods. That practical shift matters because treatment choice, isolation decisions, and culling strategies depend heavily on whether infections are contagious, environmental, acute, or persistent. As more accurate diagnostics reduce empirical treatment and shorten the time between symptom recognition and targeted intervention, they are influencing market adoption of premium testing platforms alongside pathogen-specific therapeutics and integrated herd health programs.
Growing awareness of subclinical mastitis driving preventive veterinary healthcare adoption
Greater recognition of subclinical mastitis is changing purchasing behavior in the bovine mastitis market because producers are paying closer attention to infections that do not show obvious visual symptoms but still depress milk yield, elevate somatic cell counts, and weaken herd performance over time. This has moved herd health management away from a purely reactive model toward routine screening, dry cow therapy planning, teat hygiene protocols, and regular veterinary oversight. The result is reinforcing market demand for preventive products and monitoring solutions, especially where dairy operations are under pressure to improve milk quality standards and reduce long-term productivity losses.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global dairy consumption increasing demand for effective udder infection management solutions | 1.90% | Moderate | Asia Pacific, North America | High | Near Term |
| Advancements in molecular diagnostics improving early detection and treatment accuracy for mastitis | 1.70% | High | North America, Europe | Medium | Mid Term |
| Growing awareness of subclinical mastitis driving preventive veterinary healthcare adoption | 1.40% | Moderate | Asia Pacific, Latin America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 40.00% share of the bovine mastitis market in 2025, bolstered by the region’s large commercial dairy herd base, established veterinary care networks, and routine use of diagnostic and treatment protocols on farms. Market activity is reinforced by the practical need to limit milk yield losses, protect herd health, and manage the quality impact of mastitis within intensive dairy operations. The region’s leadership is also sustained by broader access to animal health products and stronger on-farm disease monitoring, which supports consistent adoption of mastitis management solutions across both prevention and treatment settings.
Asia Pacific is projected to expand at a 9.38% CAGR over the forecast period in the bovine mastitis market, driven by the ongoing modernization of dairy farming and rising attention to productivity losses linked to udder infections. Growth is accelerating as more producers shift from small-scale, low-intervention practices toward structured herd health management, increasing the use of veterinary services, farm hygiene measures, and disease detection approaches. As dairy output expectations rise across the region, adoption is moving beyond basic treatment toward more systematic mastitis control in day-to-day farm operations.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Preventive Dairy ManagementGermany emphasizes preventive mastitis control through veterinary oversight, herd monitoring, and responsible therapeutic practices. Dairy operations in Germany continue strengthening disease surveillance to maintain animal health and support consistent milk production standards.
France 🇫🇷
Herd Monitoring StrategiesFrance focuses on comprehensive udder health management through routine screening, veterinary guidance, and preventive farm practices. Dairy producers in France are integrating monitoring technologies with herd management programs to improve treatment planning and milk quality outcomes.
Italy 🇮🇹
Veterinary Treatment OptimizationItaly strengthens bovine mastitis management through improved diagnostics, targeted treatment protocols, and preventive herd care. Dairy producers in Italy continue refining veterinary decision-making to support healthier livestock and more efficient dairy operations.
Japan 🇯🇵
Dairy Quality AssuranceJapan prioritizes early mastitis detection and consistent herd health management to support high-quality dairy production. Producers in Japan increasingly adopt diagnostic technologies that enable timely intervention while reducing production losses associated with udder infections.
South Korea 🇰🇷
Modern Livestock CareSouth Korea is expanding veterinary management practices supported by improved dairy health monitoring and disease detection tools. Dairy farms in South Korea continue investing in practical mastitis management solutions that enhance animal welfare and operational consistency.
United States 🇺🇸
Precision Herd HealthThe U.S. bovine mastitis market centers on preventive herd health management supported by advanced diagnostics and data-driven dairy monitoring. Dairy producers in the U.S. increasingly adopt integrated disease management strategies that improve milk quality and treatment efficiency.
Segment Leadership and Growth Trends
Bovine Mastitis Market Share (%), Product, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportPharmaceuticals held a 61.95% share of the bovine mastitis market in 2025, reflecting their established role as the primary treatment option once infection is identified in dairy herds. This leadership is underpinned by the routine and immediate need to manage active mastitis cases, where antibiotics and supportive drug therapies remain embedded in farm treatment protocols and veterinary practice. The pharmaceuticals segment also benefits from direct applicability across a wide range of infection severities, making it the most consistently used product category in the bovine mastitis market.
Vaccines are emerging as the fastest-growing segment in the bovine mastitis market because herd management is increasingly influenced by the need to reduce disease incidence before treatment becomes necessary. Their momentum is tied to the practical shift toward preventive health strategies, especially where farmers seek to limit recurring infections and reduce dependence on repeated pharmaceutical intervention. Compared with treatment-led alternatives, vaccines are seeing wider adoption through their fit with longer-term disease control programs and more structured udder health management approaches.
Type Segment Analysis: Clinical Mastitis (Largest Segment) vs Sub-Clinical Mastitis (Fastest-Growing Segment)
Within the bovine mastitis market, Clinical Mastitis accounted for the largest share in 2025 because it presents with visible symptoms that require immediate attention and direct intervention. Its leading position is backed by the clear economic and operational impact of symptomatic cases, which prompt faster diagnosis, treatment decisions, and veterinary involvement. Since clinical infections are more readily detected at the farm level, they continue to drive a substantial portion of product demand across the bovine mastitis market.
Sub-Clinical Mastitis is the fastest-growing segment in the bovine mastitis market as producers place greater emphasis on infections that are less visible but still affect milk quality and herd productivity. Growth in this segment is being backed by increased attention to early detection and ongoing monitoring, which brings previously underrecognized cases into formal management pathways. Relative to Clinical Mastitis, the momentum behind Sub-Clinical Mastitis comes from its closer connection to preventive herd health practices and the need to address production losses before they escalate into overt disease.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Pharmaceuticals, Antibiotics, Vaccines, Diagnostics, Others | Pharmaceuticals | Vaccines |
| Type | Clinical Mastitis, Sub-Clinical Mastitis | Clinical Mastitis | Sub-Clinical Mastitis |
| Therapy | Dry Period, Lactating Period | Dry Period | Lactating Period |
| Route of Administration | Intra-Mammary, Systemic | Intra-Mammary | Intra-Mammary |
| End-use | Veterinary Hospitals/Clinics, Others | Veterinary Hospitals/Clinics | Veterinary Hospitals/Clinics |
Competitive Landscape and Market Positioning
1. Zoetis Inc. (United States)
2. Boehringer Ingelheim International GmbH (Germany)
3. Elanco Animal Health Incorporated (United States)
4. Merck & Co. Inc. (United States)
5. Ceva Santé Animale S.A. (France)
6. HIPRA S.A. (Spain)
7. Virbac S.A. (France)
8. ImmuCell Corporation (United States)
9. Forte Healthcare Limited (New Zealand)
10. Dechra Pharmaceuticals PLC (United Kingdom)
The bovine mastitis market is experiencing growing innovation as dairy producers seek effective disease prevention and herd health management solutions. Manufacturers are developing advanced therapeutic formulations, diagnostic technologies, and preventive treatment strategies aimed at reducing infection rates and improving milk quality. Rising awareness regarding livestock productivity and animal health standards is further supporting expansion within the bovine mastitis market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Biotangents | Nov-24 | Biotangents secured £2.3 million in funding led by Eos Advisory, with participation from British Business Investments, Kelvin Capital, and Scottish Enterprise. This capital infusion is earmarked to accelerate the development and commercialization of advanced diagnostic technologies, aiming to improve the detection and clinical management of bovine mastitis within livestock health operations. |
| Boehringer Ingelheim | Apr-26 | Boehringer Ingelheim expanded its livestock health portfolio with the EU-wide launch of LENZELTA®, a mastitis vaccine for dairy cattle. This commercialization effort focuses on preventive immunization to mitigate the incidence and severity of clinical mastitis, providing dairy producers with a strategic tool to enhance herd management and operational health outcomes. |
| AHV USA | Apr-25 | AHV USA established a strategic distribution partnership with Milk Barn to integrate molecular diagnostic technology with real-time dairy monitoring systems. This collaboration seeks to improve the speed and accuracy of early mastitis detection, demonstrating a shift toward technology-enabled management solutions aimed at optimizing herd health and reducing productivity losses in dairy operations. |
| Zoetis | Aug-23 | Zoetis commercialized the Vetscan Mastigram, an on-farm diagnostic test capable of identifying Gram-positive mastitis within eight hours. By enabling rapid testing prior to the subsequent milking cycle in European markets, this product provides a functional innovation that allows for more timely therapeutic interventions and improved decision-making in bovine mastitis management. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Bovine Mastitis Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Bovine Mastitis Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the bovine mastitis market?
How much is the bovine mastitis industry expected to grow by 2035?
How are dairy productivity priorities influencing adoption of mastitis management solutions?
How are advanced diagnostics changing treatment strategies in the bovine mastitis market?
Why do pharmaceuticals lead the bovine mastitis market?
Why are vaccines the fastest-growing product segment in the bovine mastitis market?
Why does North America lead the bovine mastitis market?
What is driving Asia Pacific’s growth in bovine mastitis market?
Which companies are driving growth in the bovine mastitis landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization